Preliminary Results/ForecastDrägerwerk AG & Co. KGaA: Dräger with good demand in the first nine months of 2024 16.10.2024 / 07:00 CET/CESTThe issuer is solely responsible for the content of this ...

Generated $9.6 million Gross Revenue and $8.5 million Net Revenue in Q3 2024, establishing new company records.Record Export Wholesale Revenue1: Generated $5.1 million in Q3 2024 representing a 116% ...

Homecare Medical Devices MarketThe global homecare medical devices market is poised for significant growth, holding a forecasted value of approximately USD 133,650.67 million in 2022. This market is ...

For immediate release Nipocalimab demonstrates sustained disease control in adolescents living with generalised myasthenia gravis in the Phase 2/3 study First FcRn blocker to demonstrate sustained ...

Innovative Trials appoints new Finance and Business Services Director to drive business growth Innovative Trials, a specialist clinical trial patient engagement, recruitment, and retention company, ...

Medical Waste Management System MarketThe global medical waste management system market is set to be valued at approximately ...

Next Generation Mass Spectrometer MarketThe global next generation mass spectrometer market achieved a valuation of ...

Exonucleases MarketThe global exonucleases market, valued at approximately USD 162.6 million in 2022, is on track for steady growth over the next decade. Forecasts indicate a compound annual growth ...

Global Anti-Adhesion Barrier Gels MarketThe global anti-adhesion barrier gels market is poised for significant growth, with ...

Insulin Biosimilar MarketThe global insulin biosimilar market is on track for significant expansion, with an estimated valuation of approximately USD 3,008.0 million in 2024. Exhibiting a year-on-year ...

UCB will contribute 14 presentations, including an oral presentation, selected to feature across the AANEM and MGFA meeting, emphasizing UCB's leadership in neuromuscular researchPresentations ...

Sanofi launches high-dose egg-based quadrivalent influenza vaccine (QIV-HD) in the UK ·       Developed with a higher antigen content to increase protection in older adults, a population at greater ...